Cargando…

Malaria severity: Possible influence of the E670G PCSK9 polymorphism: A preliminary case-control study in Malian children

AIM: Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is a hepatic secretory protein which promotes the degradation of low-density lipoprotein receptors leading to reduced hepatic uptake of plasma cholesterol. Non-synonymous single-nucleotide polymorphisms in its gene have been linked to hypo-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arama, Charles, Diarra, Issa, Kouriba, Bourèma, Sirois, Francine, Fedoryak, Olesya, Thera, Mahamadou A., Coulibaly, Drissa, Lyke, Kirsten E., Plowe, Christopher V., Chrétien, Michel, Doumbo, Ogobara K., Mbikay, Majambu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813955/ https://www.ncbi.nlm.nih.gov/pubmed/29447211 http://dx.doi.org/10.1371/journal.pone.0192850

Ejemplares similares

Association of the rs562556 PCSK9 Gene Polymorphism with Reduced Mortality in Severe Malaria among Malian Children
por: Fedoryak, Olesya, et al.
Publicado: (2020)

Malian adults maintain serologic responses to virulent PfEMP1s amid seasonal patterns of fluctuation
por: Ventimiglia, Noah T., et al.
Publicado: (2021)

Malian children infected with Plasmodium ovale and Plasmodium falciparum display very similar gene expression profiles
por: Tebben, Kieran, et al.
Publicado: (2023)

Comparing expression and activity of PCSK9 in SPRET/EiJ and C57BL/6J mouse strains shows lack of correlation with plasma cholesterol()
por: Sirois, Francine, et al.
Publicado: (2016)

Long-term Maintenance of CD4 T Cell Memory Responses to Malaria Antigens in Malian Children Coinfected with Schistosoma haematobium
por: Lyke, Kirsten E., et al.
Publicado: (2018)

Protection of Malian children from clinical malaria is associated with recognition of multiple antigens
por: Daou, Modibo, et al.
Publicado: (2015)

Hemoglobin C Trait Provides Protection From Clinical Falciparum Malaria in Malian Children
por: Travassos, Mark A., et al.
Publicado: (2015)

Immunoglobulin G subclass and antibody avidity responses in Malian children immunized with Plasmodium falciparum apical membrane antigen 1 vaccine candidate FMP2.1/AS02(A)
por: Berry, Andrea A., et al.
Publicado: (2019)

Strain-specific Plasmodium falciparum growth inhibition among Malian children immunized with a blood-stage malaria vaccine
por: Laurens, Matthew B., et al.
Publicado: (2017)

Reduced T Regulatory Cell Response during Acute Plasmodium falciparum Infection in Malian Children Co-Infected with Schistosoma haematobium
por: Lyke, Kirsten E., et al.
Publicado: (2012)

Antigen-Specific B Memory Cell Responses to Plasmodium falciparum Malaria Antigens and Schistosoma haematobium Antigens in Co-Infected Malian Children
por: Lyke, Kirsten E., et al.
Publicado: (2012)

Safety and Allele-Specific Immunogenicity of a Malaria Vaccine in Malian Adults: Results of a Phase I Randomized Trial
por: Thera, Mahamadou A, et al.
Publicado: (2006)

Differential Recognition of Terminal Extracellular Plasmodium falciparum VAR2CSA Domains by Sera from Multigravid, Malaria-Exposed Malian Women
por: Travassos, Mark A., et al.
Publicado: (2015)

Quercetin-3-glucoside increases low-density lipoprotein receptor (LDLR) expression, attenuates proprotein convertase subtilisin/kexin 9 (PCSK9) secretion, and stimulates LDL uptake by Huh7 human hepatocytes in culture
por: Mbikay, Majambu, et al.
Publicado: (2014)

First characterization of methanogens in oral cavity in Malian patients with oral cavity pathologies
por: Sogodogo, Elisabeth, et al.
Publicado: (2019)

Differential effects of PCSK9 loss of function variants on serum lipid and PCSK9 levels in Caucasian and African Canadian populations
por: Mayne, Janice, et al.
Publicado: (2013)

Safety and Immunogenicity of an AMA1 Malaria Vaccine in Malian Children: Results of a Phase 1 Randomized Controlled Trial
por: Thera, Mahamadou A., et al.
Publicado: (2010)

Gene expression analyses reveal differences in children’s response to malaria according to their age
por: Tebben, Kieran, et al.
Publicado: (2023)

Candidate Polymorphisms and Severe Malaria in a Malian Population
por: Toure, Ousmane, et al.
Publicado: (2012)

Blastocystis Colonization Is Associated with Increased Diversity and Altered Gut Bacterial Communities in Healthy Malian Children
por: Kodio, Aly, et al.
Publicado: (2019)

Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara
por: Thera, Mahamadou A., et al.
Publicado: (2016)

Extended Safety, Immunogenicity and Efficacy of a Blood-Stage Malaria Vaccine in Malian Children: 24-Month Follow-Up of a Randomized, Double-Blinded Phase 2 Trial
por: Laurens, Matthew B., et al.
Publicado: (2013)

Host and Parasite Transcriptomic Changes upon Successive Plasmodium falciparum Infections in Early Childhood
por: Bradwell, Katie R., et al.
Publicado: (2020)

A high-throughput method for quantifying alleles and haplotypes of the malaria vaccine candidate Plasmodium falciparum merozoite surface protein-1 19 kDa
por: Takala, Shannon L, et al.
Publicado: (2006)

Stable malaria incidence despite scaling up control strategies in a malaria vaccine-testing site in Mali
por: Coulibaly, Drissa, et al.
Publicado: (2014)

Spatio-temporal analysis of malaria within a transmission season in Bandiagara, Mali
por: Coulibaly, Drissa, et al.
Publicado: (2013)

Spatio-Temporal Dynamics of Asymptomatic Malaria: Bridging the Gap Between Annual Malaria Resurgences in a Sahelian Environment
por: Coulibaly, Drissa, et al.
Publicado: (2017)

Gene expression analyses reveal differences in children’s response to malaria according to their age
por: Tebben, Kieran, et al.
Publicado: (2023)

Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase 1 Randomized Controlled Trial
por: Thera, Mahamadou A., et al.
Publicado: (2008)

Isoquercetin as an Anti-Covid-19 Medication: A Potential to Realize
por: Mbikay, Majambu, et al.
Publicado: (2022)

Immunogenomic profile at baseline predicts host susceptibility to clinical malaria
por: Mbambo, Gillian, et al.
Publicado: (2023)

PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial
por: Coulibaly, Drissa, et al.
Publicado: (2022)

Association of HLA alleles with Plasmodium falciparum severity in Malian children
por: Lyke, K E, et al.
Publicado: (2011)

Variation in the Circumsporozoite Protein of Plasmodium falciparum: Vaccine Development Implications
por: Gandhi, Kavita, et al.
Publicado: (2014)

Correction: Variation in the Circumsporozoite Protein of Plasmodium falciparum: Vaccine Development Implications
por: Gandhi, Kavita, et al.
Publicado: (2016)

Epigenetics and Malaria Susceptibility/Protection: A Missing Piece of the Puzzle
por: Arama, Charles, et al.
Publicado: (2018)

The enigma of soluble LDLR: could inflammation be the key?
por: Mbikay, Majambu, et al.
Publicado: (2020)

Model-based assessment of Chikungunya and O’nyong-nyong virus circulation in Mali in a serological cross-reactivity context
por: Hozé, Nathanaël, et al.
Publicado: (2021)

Author Correction: Model-based assessment of Chikungunya and O’nyong-nyong virus circulation in Mali in a serological cross-reactivity context
por: Hozé, Nathanaël, et al.
Publicado: (2023)

Acceptability and efficacy of intra-rectal quinine alkaloids as a pre-transfer treatment of non-per os malaria in peripheral health care facilities in Mopti, Mali
por: Thera, Mahamadou A, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_0ngdpg4h7aoero2toq28dbv2g9